Rakesh Amin Endocrine Ltd 07735266 false 2022-04-01 2023-03-31 2023-03-31 The principal activity of the company is that of providing general medical practice activities. Digita Accounts Production Advanced 6.30.9574.0 true 07735266 2022-04-01 2023-03-31 07735266 2023-03-31 07735266 bus:Original 2023-03-31 07735266 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 07735266 bus:Micro-entities 2022-04-01 2023-03-31 07735266 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 07735266 bus:FullAccounts 2022-04-01 2023-03-31 07735266 bus:SmallCompaniesRegimeForAccounts 2022-04-01 2023-03-31 07735266 bus:RegisteredOffice 2022-04-01 2023-03-31 07735266 bus:Director2 2022-04-01 2023-03-31 07735266 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 07735266 countries:UnitedKingdom 2022-04-01 2023-03-31 07735266 2021-04-01 2022-03-31 07735266 2022-03-31 07735266 core:CurrentFinancialInstruments core:WithinOneYear 2022-03-31 iso4217:GBP xbrli:pure

Registration number: 07735266

Rakesh Amin Endocrine Ltd

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2023

 

Rakesh Amin Endocrine Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Rakesh Amin Endocrine Ltd

Company Information

Director

Dr R Amin

Registered office

13 Montpelier Avenue
Bexley
Kent
DA5 3AP

Accountants

Kishens Limited
Chartered Accountants
13 Montpelier Avenue
Bexley
Kent
DA5 3AP

 

Rakesh Amin Endocrine Ltd

(Registration number: 07735266)
Balance Sheet as at 31 March 2023

2023
£

2022
£

Fixed Assets

14,030

78

Current assets

16,896

29,131

Creditors: Amounts falling due within one year

(21,140)

(24,308)

Net current (liabilities)/assets

(4,244)

4,823

Total assets less current liabilities

9,786

4,901

Provisions for liabilities

(2,666)

(15)

Accruals and deferred income

(1,900)

(1,800)

 

5,220

3,086

Capital and reserves

5,220

3,086

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
13 Montpelier Avenue
Bexley
Kent
DA5 3AP
England

These financial statements were authorised for issue by the director on 9 December 2023.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 2 (2022 - 2).

For the financial year ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

 

Rakesh Amin Endocrine Ltd

(Registration number: 07735266)
Balance Sheet as at 31 March 2023

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 9 December 2023
 

.........................................
Dr R Amin
Director